Using central venous catheter for suprapubic catheterization in cardiac surgery

Bilehjani, Eissa; Fakhari, Solmaz

doi:10.2147/rru.s125996

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Briefly, a single femoral approach was used, following Seldinger's technique (17), by inserting a 4-Fr catheter (RH-6SP0061i; Terumo Medical Corporation, Tokyo, Japan) over a 5-Fr introducer sheath into the celiac artery, using superior mesenteric artery angiography as well as selective hepatic arteriography to identify tumor feeders. The artery was selectively catheterized with a microcatheter/microguidewire system and embolized with a mixture of epirubicin with iodized oil (lipiodol; Laboratoire Andre Guerbet, Aulnay-sous-Bois, France).…”

Section: Tacementioning

confidence: 99%

Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization

et al. 2017

View full text Add to dashboard Cite

Abstract. Hepatocellular carcinoma (HCC) is prone to recurrence following curative treatment. The purpose of the present study was to identify the predisposing factors of HCC recurrence following complete remission achieved by transarterial chemoembolization (TACE). A retrospective cohort study of 70 consecutive patients with HCC who underwent TACE as the initial treatment was conducted. The patients were divided into two groups according to their 1-year disease-free survival (DFS) status; the early recurrence group (ER group; n=32), with HCC recurring within 1 year of initial TACE; and the non-early recurrence group (NER group; n=38), who did not experience recurrence within 1 year. The parameters identified as significantly associated with DFS time on univariate analysis were aspartate aminotransferase (AST), alanine aminotransferase and α-fetoprotein levels, as well as the tumor number (P=0.003, P=0.027, P=0.002 and P=0.005, respectively). Multivariate analysis revealed that AST levels and tumor number were significantly associated with a shorter DFS period (P=0.009 and P=0.038, respectively). The Mantel-Haenszel test revealed a significant trend of decreasing DFS with increasing tumor number. Among the patients with HCC in the ER group, locoregional recurrence occurred more frequently in those who received TACE alone compared with those treated with TACE combined with radiofrequency ablation treatment. In summary, multinodularity of HCC is the most potent predictive factor for the recurrence of HCC within 1 year of initial TACE.

show abstract

Section: Tacementioning

confidence: 99%